Close
ACHEMA MIDDLE EAST 2026

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Oracle Life Sciences has been felicitated with a couple of top honors at the 2025 Asia Pacific Biopharma Excellence Awards – ABEA. It is...

Bio-Rad to Acquire Stilla Technologies by Q3 2025

Bio-Rad Laboratories to Acquire Stilla Technologies to Expand Digital PCR Portfolio Stilla Technologies to Be Acquired by Bio-Rad Laboratories to Increase Digital PCR Portfolio A binding...

New Endometrial Cancer Care Phase II Results Encouraging

The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for...

Duality Keeps An Eye Out For Hong Kong IPO For ADC Trials

Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an...

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

Clario, a leading provider of technologies and endpoint data solutions for clinical trials announced the enhancement of its digital capture of patient mobility data...

Recursion, Exscientia Unite For $850M, 10 Trials In 18 Months

The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months,...

The Role of Partnerships In Managing Clinical Trial Costs

Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success. At the 13th Annual Clinical...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...